Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Oxazolidinone | HCID 73949 | — |
| Reactant | Methyl morpholine oxide | HCID 82029 | — |
| Reactant | Chloroform methanol | HCID 21584188 | — |
| Reactant | HCID 70193791 | HCID 70193791 | — |
| Catalyst | HCID 178419074 | HCID 178419074 | — |
| Solvent | Acetonitrile methylene chloride | HCID 21877088 | — |
| Product | HCID 9927109 | HCID 9927109 | — |
Reaction Steps
A solution of (S)-N-[[3-[3-fluoro-4-(3-hydroxy-1-azetidinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide (EXAMPLE 2, 0.440 g, 1.36 mmol) in 10% acetonitrile/dichloromethane (100 mL) was treated with powdered 4 angstrom molecular sieves (0.682 g), 4-methylmorpholine N-oxide (0.319 g, 2.72 mmol) and then tetra-n-propylammonium perruthenate (0.024 g, 0.068 mmol) at ambient temperature. After stirring 1.5 hours at ambient temperature, TLC analysis (10% methanol/chloroform) revealed a small amount of starting alcohol still remained. The addition of more 4-methylmorpholine N-oxide did not consume the starting material. The reaction mixture was concentrated under reduced pressure to a dark purple solid which was then chromatographed over silica gel (20 g), eluting with a gradient of 1-3.5% methanol/chloroform, to afford, after concentration of appropriate fractions, 0.204 g (47%) of the title oxazolidinone antibacterial agent as a white solid with mp 192°-193° C. and MS(EI) 321 (M+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05883093 |
|---|
| Source dataset | uspto-grants-1999_03 |
|---|
| ORD ID | ord-376a2923a1fa418f8722c9b0706cfd31 |
|---|
| Source note | uspto-grants-1999_03 |
|---|